| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |